Chen Thomas C's Form 4/A amendment
AmendedNeonc Technologies Holdings, Inc. (NTHI) · filed Aug 20, 2026
- Accession no.
- 0001213900-26-092276
- Filed
- Aug 20, 2026, 9:15 PM ET
- Trade date
- Apr 10-Aug 17, 2026
- Filing delay
- 132 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- Aug 18, 2026
This filing lists 4 non-derivative transactions. Open-market purchases total $192.9K. It was filed 132 days after the trade.
This amendment replaces 0001213900-26-091231 (filed Aug 18, 2026).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Chen Thomas CCIK 0001998682 | Director, Officer (Chief Scientific Officer), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 10, 2026 | Common Stock | PPurchaseAcquired | +948 | $5.17F2 | +$4,898.98 | 948 | Indirect | |
| Apr 24, 2026 | Common Stock | PPurchaseAcquired | +10,000 | $4.80 | +$48,000 | 10,000 | Indirect | |
| Aug 14, 2026 | Common Stock | PPurchaseAcquired | +33,787 | $3.85F3 | +$130,002.24 | 581,059 | Direct | |
| Aug 17, 2026 | Common Stock | PPurchaseAcquired | +2,472 | $4.04F5 | +$9,998 | 583,531 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The aggregate number of shares of Issuer's common stock (the "Shares") purchased by the Reporting Person on the same day at different prices.
- F2
Represents the weighted average purchase price. The Shares were purchased at prices ranging from $5.165 to $5.1722 per share, inclusive. Full information regarding the number of Shares sold at each price shall be provided to the Securities and Exchange Commission staff, Issuer or any security holder, upon request.
Referenced by the price of 1 transaction in Table I.
- F3
Represents the weighted average purchase price. The Shares were purchased at prices ranging from $3.2299 to $4.0993 per share, inclusive. Full information regarding the number of Shares sold at each price shall be provided to the Securities and Exchange Commission staff, Issuer or any security holder, upon request.
Referenced by the price of 1 transaction in Table I.
- F4
Includes shares of common stock held by certain members of Reporting Person's immediate family of which Reporting Person disclaims beneficial ownership except to the extent of his pecuniary interest, if any, therein.
- F5
Represents the weighted average purchase price. The Shares were purchased at prices ranging from $4.04 to $4.1699 per share, inclusive. Full information regarding the number of Shares sold at each price shall be provided to the Securities and Exchange Commission staff, Issuer or any security holder, upon request.
Referenced by the price of 1 transaction in Table I.
- F6
Such shares represent only Reporting Person's percentage interest in HCWG LLC.
- F7
Shares held by NeuCen Biomedical Co. Ltd. ("NeuCen"). NeuCen is owned in part by Reporting Person's spouse. Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest, if any, therein.
- F8
Shares held by T. R. Chen Third Family Limited Partnership, a NV limited partnership, of which Reporting Person and his spouse are the general partners with sole voting and dispositive power. Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest, if any, therein.
- F9
Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest, if any, therein.